Last reviewed · How we verify

NCT03933332

Correlation Between Muscle Thickness and Inflammation With Ventilator Use in Critically Ill Patients

Completed Last updated 2 May 2019
What this trial tests

trial testing Diaphragm thickness in Ventilation Therapy; Complications in 52 participants. Completed in 12 March 2019.

Timeline
1 October 2018
Primary endpoint
31 January 2019
12 March 2019

Quick facts

Lead sponsorIndonesia University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment52
Start date1 October 2018
Primary completion31 January 2019
Estimated completion12 March 2019
Sites1 location across Indonesia

Drugs / interventions tested

Conditions studied

Sponsor

Indonesia University

Who can join

18 and older, any sex, with Ventilation Therapy; Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Decrease thickness of diaphragm muscle, cross-sectional area of rectus femoris and biceps brachii muscle, and increase in CRP would affect ventilator length of use in critically ill patients in ICU

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Ventilation Therapy; Complications

Currently open trials in the same condition.

Other Indonesia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03933332.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing